HLLY insider filing: Carly Kennedy receives 123,724 RSUs vesting 2026-2028
Rhea-AI Filing Summary
Holley Inc. insider filing: Carly Kennedy, identified as Executive Vice President & General Counsel and reporting person, received a grant of 123,724 restricted stock units on 08/12/2025 under the companys 2021 Omnibus Incentive Plan. Each restricted stock unit converts to one share of common stock upon vesting and the units were granted at no cash price ($0). Following the grant, the reporting person beneficially owns 426,448 shares. The restricted stock units vest in equal or nearly equal installments on August 12, 2026, 2027, and 2028, subject to continuous employment.
Positive
- Equity alignment: 123,724 RSUs link executive compensation to shareholder value by converting to one share per unit upon vesting
- Retention focus: Vesting occurs over three annual installments (2026, 2027, 2028), encouraging continued employment
- No cash outlay: Grant recorded at a $0 price, indicating equity award rather than cash bonus or option purchase
Negative
- None.
Insights
TL;DR: Typical multi-year RSU award for a senior executive, aligning compensation with shareholder outcomes without immediate cash payout.
The grant is documented as restricted stock units under the 2021 Omnibus Incentive Plan, vesting over three annual installments starting August 12, 2026. The award increases the reporting person's beneficial ownership to 426,448 shares and is granted at no cash price, indicating equity-based compensation rather than immediate cash remuneration. This is a routine executive award; materiality depends on company-wide equity program size and total outstanding shares, which are not provided in this filing.
TL;DR: The structure is a standard time-based RSU grant designed to retain the executive over a three-year period.
The filing specifies 123,724 RSUs granted on 08/12/2025 with vesting in equal or nearly equal installments on August 12 of 2026, 2027, and 2028, subject to continuous employment. The award vests into one share per RSU. The grant price is recorded as $0, consistent with restricted units rather than an option exercise. The filing does not disclose performance conditions, total program run-rate, or pro forma dilution metrics, so quantitative compensation impact cannot be assessed from this form alone.